Saraheimo, M., Forsblom, C., Fagerudd, J., Teppo, A.-M., Petterson-Fernholm, K.
, Frystyk, J., Flyvbjerg, A. & Groop, P.-H. (2005).
Adiponectin is increased in type 1 diabetes with nephropathy.
Diabetes Care,
28, 1410-1414.
Saraheimo, M., Forsblom, C.
, Hansen, T. K., Fagerrud, J., Petterson-Fernholm, K., Teppo, A.-M., Ebeling, P., Thiel, S.
, Flyvbjerg, A. & Groop, P.-H. (2005).
Increased mannan-binding lectin (MBL)-levels in type 1 diabetic patients with incipient and overt nephropathy.
Diabetologia,
48, 198-202.
Schrijvers, B. F., De Vriese, A. S., Tilton, R. G., Van de Voorde, J., Denner, L., Lameire, N. H.
& Flyvbjerg, A. (2005).
Inhibition of vascular endothelial growth factor (VEGF) does not affect early renal changes in a rat model of lean type 2 diabetes.
Hormone and Metabolic Research,
37, 21-25.
Schrijvers, B., Flyvbjerg, A., Tilton, R. G.
, Rasch, R., Lameire, N. H. & De Vriese, A. S. (2005).
Pathophysiological role of vascular endothelial growth factor (VEGF) in the remnant kidney.
Nephron Experimental Nephrology,
101, e9-e15.
Sondergaard, LG., Brock, B., Stoltenberg, M., Flyvbjerg, A., Schmitz, O., Smidt, K., Danscher, G. & Rungby, J. (2005).
Zinc fluxes during acute and chronic exposure of INS-1E cells to increasing glucose levels.
Hormone and Metabolic Research,
37, 133-139.
Sørensen, V. R., Mathiassen, E. R., Clausen, P.
, Flyvbjerg, A. & Feldt-Rasmussen, B. (2005).
Impaired vascular function during short-term poor glycaemic control in Type 1 diabetic patients.
Diabetic. Med.,
22, 871-876.